These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2966309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J, Pietraszek M, Ossowska K, Wolfarth S.
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H, Ekinci AC, Starr MS.
    Brain Res; 1997 Nov 28; 777(1-2):51-9. PubMed ID: 9449412
    [Abstract] [Full Text] [Related]

  • 5. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S, Cabib S.
    Pharmacol Biochem Behav; 1988 Jul 28; 30(3):765-8. PubMed ID: 2974996
    [Abstract] [Full Text] [Related]

  • 6. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 28; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P, Chagraoui A, Arbaoui J, Mocaër E.
    Eur J Pharmacol; 1994 Dec 12; 271(1):167-77. PubMed ID: 7698199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
    Parashos SA, Marin C, Chase TN.
    Neurosci Lett; 1989 Oct 23; 105(1-2):169-73. PubMed ID: 2485878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
    Anderson JJ, Kask AM, Chase TN.
    Eur J Pharmacol; 1996 Jan 11; 295(2-3):163-8. PubMed ID: 8720580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 11; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.